VistaGen Therapeutics Depreciation & Amortization 2011-2026 | VTGN

Annual Depreciation & Amortization VistaGen Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
150 K	127 K	130 K	154 K	118 K	103 K	91.2 K	80.7 K	54.9 K	53.5 K	59.1 K	54.6 K	33.8 K	45.6 K	45.3 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
154 K	33.8 K	86.7 K

Quarterly Depreciation & Amortization VistaGen Therapeutics

2025-Q4	2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	40 K	-	-	34 K	-	-	32 K	-	30.6 K	96.2 K	32.3 K	-	43.7 K	115 K	71.2 K	-	26.4 K	25.5 K	25.4 K	-	25.5 K	77.6 K	52.1 K	26.2 K	-	64.8 K	37.9 K	-	-	-	23.6 K	-	-	37.6 K	26 K	-	-	40.8 K	28.9 K	-	-	39.2 K	26.2 K	-	-	40.2 K	25.8 K	-	-	21 K	11.8 K	-	-	33.5 K	21.3 K	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
115 K	11.8 K	39.7 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Ultragenyx Pharmaceutical RARE	35 M	$ 19.23	-3.85 %	$ 1.9 B	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Regeneron Pharmaceuticals REGN	544 M	$ 742.02	-1.94 %	$ 77.6 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Replimune Group REPL	3.5 M	$ 7.22	-4.24 %	$ 582 M	USA
REGENXBIO RGNX	15.6 M	$ 7.88	-4.6 %	$ 406 M	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Rigel Pharmaceuticals RIGL	2.42 M	$ 26.2	-0.64 %	$ 471 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Avidity Biosciences RNA	4.15 M	$ 13.09	-0.08 %	$ 1.8 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Rhythm Pharmaceuticals RYTM	500 K	$ 78.52	-4.13 %	$ 5.1 B	USA
Adaptive Biotechnologies Corporation ADPT	16 M	$ 12.57	-9.96 %	$ 1.91 B	USA
Sana Biotechnology SANA	12.8 M	$ 2.78	-8.42 %	$ 704 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	563 K	$ 5.35	7.76 %	$ 383 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 321.71	-1.96 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	546 K	$ 1.08	-0.92 %	$ 22.2 M	Israel
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA